Biotech | January 12, 2022
Sinocompound and InCatT launch new Catalyst Screening Service
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
The current annual U.S. market for prazosin hydrochloride 1mg, 2mg, 5mg strengths is approximately US $ 54 million, according to IQVIA/IMS Health
The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO
The proposed scheme to include low-income NRIs under Ayushman Bharat (PM-JAY) would ensure life-long coverage for each individual along with their spouses
The company will manufacture a cancer immunotherapy product from 2022
Approvals accorded under Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ drug intermediates and Active Pharmaceutical Ingredients (APIs
These results demonstrate the potential benefits of heterologous boosting (mix-and-match). The article describing these results have been posted on medRxiv
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
Subscribe To Our Newsletter & Stay Updated
